MIRA INFORM REPORT

 

 

 

 

Report Date :

25.03.2014

 

IDENTIFICATION DETAILS

 

Name :

MAXHEAL PHARMACEUTICALS (INDIA) LIMITED

 

 

Registered Office :

301, 3rd Floor, Maxheal House, Plot No. 169, CST No. 1043, Bangur Nagar, Goregaon (West), Mumbai – 400090, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

29.06.2009

 

 

Com. Reg. No.:

11-193624

 

 

Capital Investment / Paid-up Capital :

Rs. 10.000 Millions

 

 

CIN No.:

[Company Identification No.]

U73100MH2009PLC193624

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMM36630G

 

 

PAN No.:

[Permanent Account No.]

AAGCM0717K

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer and Supplier of Anti Infective Drugs.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (28)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 370000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject us an established company having moderate track record.

 

The borrowings of the company seems to be huge.

 

The rating takes into consideration the working capital intensive operations which results into stretched coverage indicators.

 

However, trade relations are reported to be fair. Business is active. Payments terms are reported to be slow but correct.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – December 1, 2013

 

Country Name

Previous Rating

(30.09.2013)

Current Rating

(01.12.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

INDIAN ECONOMIC OVERVIEW

 

India’s current account deficit for the fiscal third quarter ended September 2013 narrowed to $4.2 billion or 0.9 % of the gross domestic product from $31.9 billion or 6.5 % of GDP a year earlier, thanks to a pick-up in exports and moderation in gold imports. Manufacturing activity and new orders in India showed their strongest growth in a year in February. The news comes as a relief after data showed Asia’s third largest economy grew by a slower-than-expected 4.7 % annually in the three months through December. The HSBC Manufacturing Purchasing Managers’ Index which gauges the business activity of India’s factories but not its’ utilities, rose to 52.5 in February, its highest in a year from 51.4 in January. Overall new orders for factory goods which rose to a one-year high of 54.9 contributed to the surge. China has emerged as India’s biggest trading partner in the current financial year replacing the United Arab Emirates and pushing it to the third spot. India-China trade has reached $49.5 billion with a 8.7 % share in India’s total trade. The US comes second at $46 billion with 8.1 % share during the first nine months of the current financial year.

 

The Reserve Bank of India has granted an additional nine months to the public to exchange currency notes printed before 2005 including Rs 500 and Rs 1,000 denominations, pushing the deadline to January 1, 2015. A day before dates for the Lok Sabha polls were announced, the government decided to hike interest rates on fixed deposit schemes offered by post offices up to 0.2 per cent. The new rates will be effective April, 1. The Supreme Court will resume hearing on March, 11 Nokia’s appeal against a ruling over transferring ownership of its local mobile phones plant which is the subject of a tax dispute to Microsoft Corp.

 

In the last days of the current Government, another scam has surfaced. The defence ministry has ordered a probe into Hindustan Aeronautics Limited’s contracts from Britain’s Rolls-Royce Holdings worth at least $ 1.2 billion. The Central Bureau of Investigation will look into allegations that over $80 million was paid in kickbacks in a deal signed in 2011. India has asked Boeing Co. to find a solution for problems with state-owned Air India’s 787 Dreamliners. The aircraft has experienced a series of malfunctions since its debut in 2011.

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

ICRA

Rating

Long term: “B”

Rating Explanation

High risk of default.

Date

March 2013

 

Rating Agency Name

ICRA

Rating

Short term: “A4”

Rating Explanation

Minimal degree of safety. It carry very high credit risk.

Date

March 2013

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

LOCATIONS

 

Registered Office :

301, 3rd Floor, Maxheal House, Plot No. 169, CST No. 1043, Bangur Nagar, Goregaon (West), Mumbai – 400090, Maharashtra, India

Tel. No.:

91-22-42767718 (30 lines)/ 26786103/ 104

Fax No.:

91-22-26786105

E-Mail :

info@maxheal.in

hs@maxheal.in

msakhla@vsnl.com

Website :

www.maxheal.in

Location :

Owned

 

 

Head Office:

102/103, Tulsi Niwas, Pushtikar Co-Operative Society Limited, Jogeshwari (West), Mumbai – 400 102, Maharashtra, India

Tel. No.:

91-22-42767718 (30 lines)/ 26786103/ 104

Fax No.:

91-22-26786105

E-Mail :

info@maxheal.in 

 

 

Factory :

95/6, MIDC, Satpur, Nashik – 422 007, Maharashtra, India

Tel. No.:

91-253-2350021

Fax No.:

91-253-2353951

Email:

nsk@maxheal.in

 

 

DIRECTORS

 

As on: 30.09.2013

 

Name :

Mr. Madan Mohanlal Sakhala

Designation :

Director

Address :

A-702, Rushi Tower, Plot No. 1, Near Green Acres, Samarth Nagar, Andheri (West), Mumbai – 400053, Maharashtra, India

Date of Birth/Age :

04.11.1948

Date of Appointment :

21.12.2014

PAN No.:

AAPPS5474H

DIN No.:

00475606

 

 

Name :

Mrs. Hemlata Madan Sakhala

Designation :

Director

Address :

A-702, Rushi Tower, Plot No. 1, Near Green Acres, Samarth Nagar, Andheri (West), Mumbai – 400053, Maharashtra, India

Date of Birth/Age :

26.09.1951

Date of Appointment :

21.12.2014

PAN No.:

AAPPS5473A

DIN No.:

00475674

 

 

Name :

Mr. Mehul Madan Sakhala

Designation :

Director

Address :

A-702, Rushi Tower, Plot No. 1, Near Green Acres, Samarth Nagar, Andheri (West), Mumbai – 400053, Maharashtra, India

Date of Birth/Age :

03.06.1985

Date of Appointment :

01.04.2006

PAN No.:

AVCPS6796D

DIN No.:

00475715

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on: 30.09.2013

 

Names of Shareholders

 

No. of Shares

http://www.bseindia.com/include/images/clear.gif Madan Mohanlal Sakhala

 

720000

http://www.bseindia.com/include/images/clear.gifHemlata Madan Sakhala

 

230000

http://www.bseindia.com/include/images/clear.gifMadan Mohanlal Sakhala (HUF)

 

10000

Mehul Madan Sakhala

 

10000

Rachana Kalpesh Loonawat

 

10000

Priya Atul Lalwani

 

10000

Manish Kamlesh Kothari

 

10000

 

 

 

Total

 

1000000

 

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on: 30.09.2013

 

Category

 

Percentage

 

 

 

Directors or relatives of directors

 

100.00

 

 

 

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Supplier of Anti Infective Drugs

 

PRODUCTION STATUS AS ON 31.03.2013

 

Particulars

Unit

Installed Capacity

Actual Production

Tablets

Lacs

14976

2230.08

Capsules

Lacs

9000

942.15

 

 

GENERAL INFORMATION

 

No. of Employees :

Information declined by the management. 

 

 

Bankers :

Oriental Bank of Commerce, Malad (West) Branch, Vikas Chambers, Link Road, Malad West, Mumbai - 400064, Maharashtra, India

 

 

Facilities :

(Rs. In Millions)

Secured Loan

As on

31.03.2013

As on

31.03.2013

Long term borrowings

 

 

Axis Bank car loan

2.359

2.981

Loans from S.E. Investment

0.000

13.750

Mr. Madan M. Sakhala and Mrs. Hemlata Madam Sakhala  Payment in 125 EMI 

14.889

15.660

Western Maharashtra Development Corporation 

0.002

0.005

Sales tax Deferred Scheme

6.538

7.512

 

 

 

Short term borrowings

 

 

Packing Credit limit

34.641

92.561

Packing credit limit foreign currency 

85.353

29.183

 

 

 

Total

143.782

161.652

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

S.B. Chhajed and Company

Chartered Accountants

Address :

202, Inder Tower, Kaka Saheb Gadgil Marg, Dadar (West), Mumbai – 400025, Maharashtra, India

PAN No.:

ABCFS0439E

 

 

Related Party:

·         Maxheal Laboratories Private limited

·         Ally Pharma Options Private Limited

 

 

CAPITAL STRUCTURE

 

As on: 30.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1000000

Equity Shares

Rs.10/- each

Rs. 10.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

 

 

1000000

Equity Shares

Rs.10/- each

Rs. 10.000 Millions

 

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

 

31.03.2012

 

31.03.2011

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

10.000

10.000

10.000

(b) Reserves & Surplus

83.630

58.898

38.545

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

93.630

68.898

48.545

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

51.176

59.809

158.208

(b) Deferred tax liabilities (Net)

0.369

0.847

0.333

(c) Other long term liabilities

0.000

0.028

0.028

(d) long-term provisions

0.197

0.197

0.201

Total Non-current Liabilities (3)

51.742

60.881

158.770

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

119.995

131.994

0.000

(b) Trade payables

132.463

198.387

211.861

(c) Other current liabilities

22.149

31.742

10.449

(d) Short-term provisions

11.000

6.513

0.990

Total Current Liabilities (4)

285.607

368.636

223.300

 

 

 

 

TOTAL

430.979

498.415

430.615

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

27.563

27.749

29.991

(ii) Intangible Assets

10.023

12.481

10.341

(iii) Capital work-in-progress

1.000

5.208

1.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

47.369

42.912

42.912

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

23.138

35.729

20.148

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

109.093

124.079

104.392

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

68.684

74.282

143.487

(c) Trade receivables

196.874

243.155

139.542

(d) Cash and cash equivalents

14.228

5.095

2.313

(e) Short-term loans and advances

42.012

51.710

40.831

(f) Other current assets

0.088

0.094

0.050

Total Current Assets

321.886

374.336

326.223

 

 

 

 

TOTAL

430.979

498.415

430.615

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

Income

531.678

624.731

593.362

 

Excise Duty

0.056

(0.955)

0.000

 

Other Income

28.817

29.000

11.069

 

TOTAL (A)

560.551

652.776

604.431

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

426.611

499.740

495.470

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

3.173

27.421

(14.180)

 

Employees benefits expense

31.570

35.500

29.915

 

Other expenses

33.329

36.355

31.871

 

TOTAL (B)

494.683

599.016

543.076

 

 

 

 

 

Less

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (C)

65.868

53.760

61.355

 

 

 

 

 

Less

FINANCIAL EXPENSES (D)

21.700

21.653

18.125

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E)

44.168

32.107

43.230

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION (F)

8.456

5.336

5.717

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX (E-F)   (G)

35.712

26.771

37.513

 

 

 

 

 

Less

TAX (I)

10.981

6.418

8.591

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX  (G-I)   (J)

24.731

20.353

28.922

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

506.927

0.000

0.000

 

TOTAL EARNINGS

506.927

0.000

0.000

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

66.127

0.000

0.000

 

TOTAL IMPORTS

66.127

0.000

0.000

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

24.73

20.35

28.92

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

4.41

3.11

4.78

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

6.71

4.29

6.32

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

9.33

5.95

9.70

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.38

0.39

0.77

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

1.82

2.78

3.26

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.13

1.01

1.46

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

10.000

10.000

10.000

Reserves & Surplus

38.545

58.898

83.630

Net worth

48.545

68.898

93.630

 

 

 

 

long-term borrowings

158.208

59.809

51.176

Short term borrowings

0.000

131.994

119.995

Total borrowings

158.208

191.803

171.171

Debt/Equity ratio

3.259

2.784

1.828

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

593.362

624.731

531.678

 

 

5.287

(14.895)

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

593.362

624.731

531.678

Profit

28.922

20.353

24.731

 

4.87%

3.26%

4.65%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

UNSECURED LOAN

(Rs. In Millions)

Particulars

As on

31.03.2013

As on

31.03.2013

Long term borrowings

 

 

Anant Behere

0.010

0.010

Olenmark Pharma

0.284

0.284

Distributors Deposits 

0.060

0.060

Leesan Distributors

0.004

0.003

Deposits from medical representative

0.020

0.020

Hemant distributors

0.111

0.000

Loans and advance from related parties 

26.088

16.311

Loans and advance from others

0.812

3.213

 

 

 

Short term borrowings

 

 

From others

0.000

10.250

 

 

 

Total

27.389

30.151

 

FINANCIAL RESULTS

 

The financial results for the fourth year comprising of full period of twelve months have slighty been declined. During the year under report, company has achieved a sales turnover of Rs. 531.678 Millions (Previous Year Rs. 624.732 Millions). The local sales turnover during the year under report Rs. 5.732 Millions (Previous Year Rs. 6.547 Millions) and export turnover was of Rs. 525.946 Millions (Previous Year Rs. 618.185 Millions). After having regard to appropriation and provisions, there are was a profit of Rs. 25.253 Millions (Previous year loss of Rs. 20.354 Millions) which has been to balance sheet.

 

Note :

Registered office of the company has been shifted from 102/103 Tulsi Niwaspustikar Co-Operative Society Limited, Jogeshwari (West), MUMBAI-400102, Maharashtra, India to the present address w.e.f. 01.11.2013.

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10306801

28/12/2012 *

200,000,000.00

ORIENTAL BANK OF COMMERCE

MALAD (WEST) BRANCH, VIKAS CHAMBERS, LINK ROAD, MALAD WEST, MUMBAI, MAHARASHTRA - 400064, INDIA

B66255365

2

10233440

13/07/2010

129,400,000.00

STATE BANK OF INDIA

SIR P. M. ROAD BRANCH, GRESHAM HOUSE, GROUND FLOOR, FORT, MUMBAI, MAHARASHTRA - 400001, INDIA

A91298679

3

10213957

28/12/2012 *

200,000,000.00

ORIENTAL BANK OF COMMERCE

MALAD (WEST) BRANCH, VIKAS CHAMBERS, LINK ROAD, MALAD WEST, MUMBAI, MAHARASHTRA - 400064, INDIA

B66255191

 

* Date of charge modification

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 60.70

UK Pound

1

Rs. 100.11

Euro

1

Rs.83.81

 

 

INFORMATION DETAILS

 

Report Prepared by :

DPH

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

4

--CREDIT LINES

1~10

3

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

28

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.